Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung
- PMID: 10649246
Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung
Abstract
Background: Neuroendocrine neoplasms of the lung represent a wide spectrum of phenotypically and biologically distinct entities. Their histopathologic diagnosis, which carries therapeutic and prognostic significance, may sometimes be difficult because of their overlapping features. We previously demonstrated that large cell neuroendocrine carcinomas (LCNECs) and small cell lung carcinomas (SCLCs) failed to show positive nuclear staining of RB protein (RB-), whereas typical and atypical carcinoids (TCs and ACs) showed nuclear RB immunostaining (RB+).
Methods: In the current study, a series of 58 surgically resected lung tumors, of which 33 tumors were initially diagnosed as SCLCs and 25 as TCs or ACs, were studied for RB and p16 protein expression by immunohistochemistry. They were also reviewed for their pathologic diagnosis; the reviewers were blinded to the RB and p16 protein status.
Results: Nineteen tumors were diagnosed as TCs, 5 as ACs, 7 as LCNECs, and 27 as SCLCs. Three of seven LCNECs were RB+, whereas the other four were RB-. In contrast, all 19 TCs were RB+ and all 27 SCLCs were RB-. In addition, two of five ACs were RB+, whereas the other three were RB-. Interestingly, all 3 RB+ LCNECs and the 1 RB+ AC tested failed to show nuclear staining of p16 protein in any tumor cells (p16-), although some normal stromal cells showed nuclear staining of p16 protein (p16+) as positive internal controls, indicating loss of p16 function in these tumors. It is also noteworthy that the three RB+ LCNECs were initially diagnosed as SCLCs and one of the RB- ACs was initially considered a TC. With the exception of TCs, tumors were significantly more prevalent among heavy smokers with >20 pack-years compared with nonsmokers and light smokers with < or = 20 pack-years (P < 0.01).
Conclusions: These findings suggest that all SCLCs and LCNECs have abnormalities in the p16:RB pathway, as do at least certain ACs, whereas the p16:RB pathway is normal in TCs.
Copyright 2000 American Cancer Society.
Similar articles
-
The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.Hum Pathol. 2003 Feb;34(2):136-42. doi: 10.1053/hupa.2003.8. Hum Pathol. 2003. PMID: 12612881
-
Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.Am J Pathol. 1996 May;148(5):1531-41. Am J Pathol. 1996. PMID: 8623922 Free PMC article.
-
Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.Mod Pathol. 1996 May;9(5):484-90. Mod Pathol. 1996. PMID: 8733762
-
Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Biochim Biophys Acta. 2012. PMID: 22579738 Review.
-
Molecular genetics of small cell lung carcinoma.Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Semin Oncol. 2001. PMID: 11479891 Review.
Cited by
-
MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.J Exp Clin Cancer Res. 2010 Jun 17;29(1):75. doi: 10.1186/1756-9966-29-75. J Exp Clin Cancer Res. 2010. PMID: 20624269 Free PMC article.
-
Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.Cancer Sci. 2004 Apr;95(4):334-41. doi: 10.1111/j.1349-7006.2004.tb03212.x. Cancer Sci. 2004. PMID: 15072592 Free PMC article.
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.Sci Transl Med. 2011 Mar 23;3(75):75ra26. doi: 10.1126/scitranslmed.3002003. Sci Transl Med. 2011. PMID: 21430269 Free PMC article.
-
SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.Mod Pathol. 2017 May;30(5):660-671. doi: 10.1038/modpathol.2016.222. Epub 2017 Jan 20. Mod Pathol. 2017. PMID: 28106103
-
A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid.Cancers (Basel). 2022 Jun 30;14(13):3234. doi: 10.3390/cancers14133234. Cancers (Basel). 2022. PMID: 35805004 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical